#' Obtain the Cadot_leukemia data
#'
#' Obtain the leukemia time-course PMBC CITE-seq data from Cadot et al (2020).
#'
#' @details
#'CITE-seq at 3 timepoints of one patient undergoing Ibrutinib treatment
#'for chronic lymphocytic leukemia.  PMBCs were stained with a cocktail of 11
#'antibodies (Biolegend) and 1 isotype control.  The isotype control is not
#'included in the data.
#'
#'A table of donor characteristics is available in Additional Table 1 of
#'the original manuscript.
#'
#'Data was downloaded from
#'\url{https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE152469}
#'
#'@references
#'Cadot, Sarah, et al. "Longitudinal CITE-Seq profiling of
#'chronic lymphocytic leukemia during ibrutinib treatment:
#'evolution of leukemic and immune cells at relapse." Biomarker
#'research 8.1 (2020): 1-13.
#'\doi{https://doi.org/10.1186/s40364-020-00253-w}
#'
#'@export
Cadot_leukemia <- function(){

}
